What is being studied?
Researchers have examined whether gabapentin prescriptions are associated with later dementia or mild cognitive impairment. A 2025 study of adults with chronic low back pain reported an association. It used existing health records, so it could not establish cause and effect.
Read the original 2025 study ↗The evidence has limits
A 2026 systematic review of observational studies reported higher pooled estimates of dementia risk with gabapentinoid use, while rating the overall certainty of evidence as low. The review examined a drug class that includes gabapentin and pregabalin; its findings are not an individual prediction. Differences among studies and remaining confounding limit interpretation.
Read the 2026 systematic review ↗Research is not uniform. A separate study in older adults with cognitive impairment found no association with cognitive or functional decline over one or two years, while finding an association with falls. That population and follow-up period differ from the low-back-pain study.
Read the study in older adults ↗Memory symptoms are not a diagnosis
Forgetfulness, confusion or difficulty concentrating can have many causes. Talk with a clinician about new or worsening symptoms and bring a current medication list. Do not assume that gabapentin is the cause or change treatment on your own.
Information that can help a review
- When gabapentin was started, stopped or changed.
- The exact diagnosis, diagnosing clinician and date.
- Pharmacy records identifying the product and manufacturer.
- Other medicines, health conditions and earlier cognitive symptoms.
- Changes in daily functioning and any caregiving needs.
A diagnosis after exposure is a starting point for investigation, not proof of causation or a guarantee of a claim.
Build your records checklist ↗Separate symptoms, diagnosis and medication dates
Record when symptoms were first noticed, when a clinician diagnosed the condition and when each medicine began. These dates can differ. Our October study explainer shows why existing dementia and new diagnoses must be distinguished.
Separate postoperative confusion from a dementia diagnosis
An October 11, 2026 observational lumbar-fusion study examined 303 patients aged 65 or older and postoperative delirium, pain and opioid dose. It did not find a statistically significant difference in delirium incidence or clinically important pain or opioid-dose reductions. It does not establish long-term dementia causation. Preserve the clinician's actual diagnosis and timing rather than relabeling all cognitive symptoms as dementia.
